CARDIOVASCULAR RESEARCH-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2360820, encodeId=4df2236082078, content=投稿周期短，可以考虑～, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8f110016014, createdName=ms7000001543812798, createdTime=Thu Aug 27 11:00:41 CST 2026, time=2026-08-27, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2259893, encodeId=e9cf2259893e8, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：心脏瓣膜材料综述 经验分享：综述投稿 3月19 submitted to journal 3月27 直接就是Decision in Progress，这是什么意思，而且现在已经半个月还是Decision in Progress。有没有大佬经历过，求解答, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8599517450, createdName=ms5000001778422266, createdTime=Thu Apr 10 11:38:26 CST 2025, time=2025-04-10, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2166745, encodeId=e9ed2166e4569, content=10月24投的目前仍然submitted to journal 好慢啊有经验的大神可以告知下吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1178, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e6a65458119, createdName=ms1000001139242253, createdTime=Sun Nov 05 01:42:59 CST 2023, time=2023-11-05, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2130917, encodeId=c84f213091eac, content=投稿命中率:50.0 偏重的研究方向：心血管 经验分享：先看看吧，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1211, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2c38538526, createdName=ms7000002097157659, createdTime=Mon May 08 09:19:39 CST 2023, time=2023-05-08, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2269574, encodeId=d36a22695e428, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：修回under review之后变成all review completed已经6天，还没有收到意见。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJVbM5G1znabWwzvc0npgCQJMIpTJ2uiaNy7RDbTrjYicEw5DvukA50wqL8YJ8SzXEsxM7SPuzVeBibg/0, createdBy=20682164487, createdName=ms7323538649197238, createdTime=Mon Jun 16 10:16:25 CST 2025, time=2025-06-16, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2259889, encodeId=b6b722598892c, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：心脏瓣膜材料综述 经验分享：投稿综述 3月19 submitted to journal 3月27 直接就是Decision in Progress是什么意思，而且现在已经半个月了，还是Decision in Progress。 有经历过的大佬吗，求解答，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8599517450, createdName=ms5000001778422266, createdTime=Thu Apr 10 11:25:20 CST 2025, time=2025-04-10, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2249259, encodeId=32242249259d2, content=1.10 投稿 1.15 改格式 1.17 with editor 1.22 under review 这里的under review是外审吗？还是只是编辑内审呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=189, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230127/dd490db5809c41dba47efd8445d736af/b6403d79e2fb4308b2f2b14ee7a06741.jpg, createdBy=1f234693702, createdName=白衣13, createdTime=Thu Jan 23 07:54:07 CST 2025, time=2025-01-23, status=1, ipAttribution=新南威尔士), GetPortalCommentsPageByObjectIdResponse(id=2116289, encodeId=9ad2211628998, content=请问投了以后2月15 显示 with eidtor ，然后更新了日期2月21日，但是还是显示 with eidtor。这是代表还没送审吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1498, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=925a4886082, createdName=759706283, createdTime=Fri Feb 24 15:40:31 CST 2023, time=2023-02-24, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2221616, encodeId=a3e1222161693, content=revision submitted to journal 16天了，好慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1499, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ae035128370, createdName=1464e744m37暂无昵称, createdTime=Tue Aug 20 23:42:56 CST 2024, time=2024-08-20, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2113953, encodeId=a2762113953ec, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：心血管领域非常专业的杂志，认可度高。从投稿到接收用了5个月。重视动物实验和详细的机制，创新性强时数据量不大也可发表。杂志会邀请客座编辑对文章进行评估，一般都是领域内的大牛。外审意见返回后，客座编辑会综合意见并提出自己的看法和要求。杂志有专门的团队帮忙润色，水平非常高！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1652, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0da81966598, createdName=wslyxblxx, createdTime=Fri Feb 10 12:58:06 CST 2023, time=2023-02-10, status=1, ipAttribution=河南省)]

2026-08-27 ms7000001543812798 来自广西

投稿周期短，可以考虑～

3 0 举报

[GetPortalCommentsPageByObjectIdResponse(id=2360820, encodeId=4df2236082078, content=投稿周期短，可以考虑～, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8f110016014, createdName=ms7000001543812798, createdTime=Thu Aug 27 11:00:41 CST 2026, time=2026-08-27, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2259893, encodeId=e9cf2259893e8, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：心脏瓣膜材料综述 经验分享：综述投稿 3月19 submitted to journal 3月27 直接就是Decision in Progress，这是什么意思，而且现在已经半个月还是Decision in Progress。有没有大佬经历过，求解答, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8599517450, createdName=ms5000001778422266, createdTime=Thu Apr 10 11:38:26 CST 2025, time=2025-04-10, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2166745, encodeId=e9ed2166e4569, content=10月24投的目前仍然submitted to journal 好慢啊有经验的大神可以告知下吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1178, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e6a65458119, createdName=ms1000001139242253, createdTime=Sun Nov 05 01:42:59 CST 2023, time=2023-11-05, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2130917, encodeId=c84f213091eac, content=投稿命中率:50.0 偏重的研究方向：心血管 经验分享：先看看吧，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1211, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2c38538526, createdName=ms7000002097157659, createdTime=Mon May 08 09:19:39 CST 2023, time=2023-05-08, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2269574, encodeId=d36a22695e428, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：修回under review之后变成all review completed已经6天，还没有收到意见。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJVbM5G1znabWwzvc0npgCQJMIpTJ2uiaNy7RDbTrjYicEw5DvukA50wqL8YJ8SzXEsxM7SPuzVeBibg/0, createdBy=20682164487, createdName=ms7323538649197238, createdTime=Mon Jun 16 10:16:25 CST 2025, time=2025-06-16, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2259889, encodeId=b6b722598892c, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：心脏瓣膜材料综述 经验分享：投稿综述 3月19 submitted to journal 3月27 直接就是Decision in Progress是什么意思，而且现在已经半个月了，还是Decision in Progress。 有经历过的大佬吗，求解答，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8599517450, createdName=ms5000001778422266, createdTime=Thu Apr 10 11:25:20 CST 2025, time=2025-04-10, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2249259, encodeId=32242249259d2, content=1.10 投稿 1.15 改格式 1.17 with editor 1.22 under review 这里的under review是外审吗？还是只是编辑内审呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=189, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230127/dd490db5809c41dba47efd8445d736af/b6403d79e2fb4308b2f2b14ee7a06741.jpg, createdBy=1f234693702, createdName=白衣13, createdTime=Thu Jan 23 07:54:07 CST 2025, time=2025-01-23, status=1, ipAttribution=新南威尔士), GetPortalCommentsPageByObjectIdResponse(id=2116289, encodeId=9ad2211628998, content=请问投了以后2月15 显示 with eidtor ，然后更新了日期2月21日，但是还是显示 with eidtor。这是代表还没送审吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1498, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=925a4886082, createdName=759706283, createdTime=Fri Feb 24 15:40:31 CST 2023, time=2023-02-24, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2221616, encodeId=a3e1222161693, content=revision submitted to journal 16天了，好慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1499, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ae035128370, createdName=1464e744m37暂无昵称, createdTime=Tue Aug 20 23:42:56 CST 2024, time=2024-08-20, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2113953, encodeId=a2762113953ec, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：心血管领域非常专业的杂志，认可度高。从投稿到接收用了5个月。重视动物实验和详细的机制，创新性强时数据量不大也可发表。杂志会邀请客座编辑对文章进行评估，一般都是领域内的大牛。外审意见返回后，客座编辑会综合意见并提出自己的看法和要求。杂志有专门的团队帮忙润色，水平非常高！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1652, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0da81966598, createdName=wslyxblxx, createdTime=Fri Feb 10 12:58:06 CST 2023, time=2023-02-10, status=1, ipAttribution=河南省)]

2025-04-10 ms5000001778422266 来自湖北省

审稿速度:1.0 | 投稿命中率:50.0
偏重的研究方向：心脏瓣膜材料综述
经验分享：综述投稿 3月19 submitted to journal 3月27 直接就是Decision in Progress，这是什么意思，而且现在已经半个月还是Decision in Progress。有没有大佬经历过，求解答

174 4 举报

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2360820, encodeId=4df2236082078, content=投稿周期短，可以考虑～, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8f110016014, createdName=ms7000001543812798, createdTime=Thu Aug 27 11:00:41 CST 2026, time=2026-08-27, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2259893, encodeId=e9cf2259893e8, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：心脏瓣膜材料综述 经验分享：综述投稿 3月19 submitted to journal 3月27 直接就是Decision in Progress，这是什么意思，而且现在已经半个月还是Decision in Progress。有没有大佬经历过，求解答, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8599517450, createdName=ms5000001778422266, createdTime=Thu Apr 10 11:38:26 CST 2025, time=2025-04-10, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2166745, encodeId=e9ed2166e4569, content=10月24投的目前仍然submitted to journal 好慢啊有经验的大神可以告知下吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1178, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e6a65458119, createdName=ms1000001139242253, createdTime=Sun Nov 05 01:42:59 CST 2023, time=2023-11-05, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2130917, encodeId=c84f213091eac, content=投稿命中率:50.0 偏重的研究方向：心血管 经验分享：先看看吧，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1211, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2c38538526, createdName=ms7000002097157659, createdTime=Mon May 08 09:19:39 CST 2023, time=2023-05-08, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2269574, encodeId=d36a22695e428, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：修回under review之后变成all review completed已经6天，还没有收到意见。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJVbM5G1znabWwzvc0npgCQJMIpTJ2uiaNy7RDbTrjYicEw5DvukA50wqL8YJ8SzXEsxM7SPuzVeBibg/0, createdBy=20682164487, createdName=ms7323538649197238, createdTime=Mon Jun 16 10:16:25 CST 2025, time=2025-06-16, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2259889, encodeId=b6b722598892c, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：心脏瓣膜材料综述 经验分享：投稿综述 3月19 submitted to journal 3月27 直接就是Decision in Progress是什么意思，而且现在已经半个月了，还是Decision in Progress。 有经历过的大佬吗，求解答，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8599517450, createdName=ms5000001778422266, createdTime=Thu Apr 10 11:25:20 CST 2025, time=2025-04-10, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2249259, encodeId=32242249259d2, content=1.10 投稿 1.15 改格式 1.17 with editor 1.22 under review 这里的under review是外审吗？还是只是编辑内审呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=189, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230127/dd490db5809c41dba47efd8445d736af/b6403d79e2fb4308b2f2b14ee7a06741.jpg, createdBy=1f234693702, createdName=白衣13, createdTime=Thu Jan 23 07:54:07 CST 2025, time=2025-01-23, status=1, ipAttribution=新南威尔士), GetPortalCommentsPageByObjectIdResponse(id=2116289, encodeId=9ad2211628998, content=请问投了以后2月15 显示 with eidtor ，然后更新了日期2月21日，但是还是显示 with eidtor。这是代表还没送审吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1498, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=925a4886082, createdName=759706283, createdTime=Fri Feb 24 15:40:31 CST 2023, time=2023-02-24, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2221616, encodeId=a3e1222161693, content=revision submitted to journal 16天了，好慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1499, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ae035128370, createdName=1464e744m37暂无昵称, createdTime=Tue Aug 20 23:42:56 CST 2024, time=2024-08-20, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2113953, encodeId=a2762113953ec, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：心血管领域非常专业的杂志，认可度高。从投稿到接收用了5个月。重视动物实验和详细的机制，创新性强时数据量不大也可发表。杂志会邀请客座编辑对文章进行评估，一般都是领域内的大牛。外审意见返回后，客座编辑会综合意见并提出自己的看法和要求。杂志有专门的团队帮忙润色，水平非常高！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1652, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0da81966598, createdName=wslyxblxx, createdTime=Fri Feb 10 12:58:06 CST 2023, time=2023-02-10, status=1, ipAttribution=河南省)]

2023-11-05 ms1000001139242253 来自山东省

10月24投的目前仍然submitted to journal 好慢啊有经验的大神可以告知下吗

1178 2 举报

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2360820, encodeId=4df2236082078, content=投稿周期短，可以考虑～, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8f110016014, createdName=ms7000001543812798, createdTime=Thu Aug 27 11:00:41 CST 2026, time=2026-08-27, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2259893, encodeId=e9cf2259893e8, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：心脏瓣膜材料综述 经验分享：综述投稿 3月19 submitted to journal 3月27 直接就是Decision in Progress，这是什么意思，而且现在已经半个月还是Decision in Progress。有没有大佬经历过，求解答, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8599517450, createdName=ms5000001778422266, createdTime=Thu Apr 10 11:38:26 CST 2025, time=2025-04-10, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2166745, encodeId=e9ed2166e4569, content=10月24投的目前仍然submitted to journal 好慢啊有经验的大神可以告知下吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1178, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e6a65458119, createdName=ms1000001139242253, createdTime=Sun Nov 05 01:42:59 CST 2023, time=2023-11-05, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2130917, encodeId=c84f213091eac, content=投稿命中率:50.0 偏重的研究方向：心血管 经验分享：先看看吧，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1211, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2c38538526, createdName=ms7000002097157659, createdTime=Mon May 08 09:19:39 CST 2023, time=2023-05-08, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2269574, encodeId=d36a22695e428, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：修回under review之后变成all review completed已经6天，还没有收到意见。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJVbM5G1znabWwzvc0npgCQJMIpTJ2uiaNy7RDbTrjYicEw5DvukA50wqL8YJ8SzXEsxM7SPuzVeBibg/0, createdBy=20682164487, createdName=ms7323538649197238, createdTime=Mon Jun 16 10:16:25 CST 2025, time=2025-06-16, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2259889, encodeId=b6b722598892c, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：心脏瓣膜材料综述 经验分享：投稿综述 3月19 submitted to journal 3月27 直接就是Decision in Progress是什么意思，而且现在已经半个月了，还是Decision in Progress。 有经历过的大佬吗，求解答，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8599517450, createdName=ms5000001778422266, createdTime=Thu Apr 10 11:25:20 CST 2025, time=2025-04-10, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2249259, encodeId=32242249259d2, content=1.10 投稿 1.15 改格式 1.17 with editor 1.22 under review 这里的under review是外审吗？还是只是编辑内审呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=189, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230127/dd490db5809c41dba47efd8445d736af/b6403d79e2fb4308b2f2b14ee7a06741.jpg, createdBy=1f234693702, createdName=白衣13, createdTime=Thu Jan 23 07:54:07 CST 2025, time=2025-01-23, status=1, ipAttribution=新南威尔士), GetPortalCommentsPageByObjectIdResponse(id=2116289, encodeId=9ad2211628998, content=请问投了以后2月15 显示 with eidtor ，然后更新了日期2月21日，但是还是显示 with eidtor。这是代表还没送审吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1498, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=925a4886082, createdName=759706283, createdTime=Fri Feb 24 15:40:31 CST 2023, time=2023-02-24, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2221616, encodeId=a3e1222161693, content=revision submitted to journal 16天了，好慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1499, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ae035128370, createdName=1464e744m37暂无昵称, createdTime=Tue Aug 20 23:42:56 CST 2024, time=2024-08-20, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2113953, encodeId=a2762113953ec, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：心血管领域非常专业的杂志，认可度高。从投稿到接收用了5个月。重视动物实验和详细的机制，创新性强时数据量不大也可发表。杂志会邀请客座编辑对文章进行评估，一般都是领域内的大牛。外审意见返回后，客座编辑会综合意见并提出自己的看法和要求。杂志有专门的团队帮忙润色，水平非常高！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1652, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0da81966598, createdName=wslyxblxx, createdTime=Fri Feb 10 12:58:06 CST 2023, time=2023-02-10, status=1, ipAttribution=河南省)]

2023-05-08 ms7000002097157659 来自安徽省

投稿命中率:50.0
偏重的研究方向：心血管
经验分享：先看看吧，

1211 20 举报

展开20条回复

[GetPortalCommentsPageByObjectIdResponse(id=2360820, encodeId=4df2236082078, content=投稿周期短，可以考虑～, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8f110016014, createdName=ms7000001543812798, createdTime=Thu Aug 27 11:00:41 CST 2026, time=2026-08-27, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2259893, encodeId=e9cf2259893e8, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：心脏瓣膜材料综述 经验分享：综述投稿 3月19 submitted to journal 3月27 直接就是Decision in Progress，这是什么意思，而且现在已经半个月还是Decision in Progress。有没有大佬经历过，求解答, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8599517450, createdName=ms5000001778422266, createdTime=Thu Apr 10 11:38:26 CST 2025, time=2025-04-10, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2166745, encodeId=e9ed2166e4569, content=10月24投的目前仍然submitted to journal 好慢啊有经验的大神可以告知下吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1178, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e6a65458119, createdName=ms1000001139242253, createdTime=Sun Nov 05 01:42:59 CST 2023, time=2023-11-05, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2130917, encodeId=c84f213091eac, content=投稿命中率:50.0 偏重的研究方向：心血管 经验分享：先看看吧，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1211, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2c38538526, createdName=ms7000002097157659, createdTime=Mon May 08 09:19:39 CST 2023, time=2023-05-08, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2269574, encodeId=d36a22695e428, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：修回under review之后变成all review completed已经6天，还没有收到意见。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJVbM5G1znabWwzvc0npgCQJMIpTJ2uiaNy7RDbTrjYicEw5DvukA50wqL8YJ8SzXEsxM7SPuzVeBibg/0, createdBy=20682164487, createdName=ms7323538649197238, createdTime=Mon Jun 16 10:16:25 CST 2025, time=2025-06-16, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2259889, encodeId=b6b722598892c, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：心脏瓣膜材料综述 经验分享：投稿综述 3月19 submitted to journal 3月27 直接就是Decision in Progress是什么意思，而且现在已经半个月了，还是Decision in Progress。 有经历过的大佬吗，求解答，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8599517450, createdName=ms5000001778422266, createdTime=Thu Apr 10 11:25:20 CST 2025, time=2025-04-10, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2249259, encodeId=32242249259d2, content=1.10 投稿 1.15 改格式 1.17 with editor 1.22 under review 这里的under review是外审吗？还是只是编辑内审呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=189, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230127/dd490db5809c41dba47efd8445d736af/b6403d79e2fb4308b2f2b14ee7a06741.jpg, createdBy=1f234693702, createdName=白衣13, createdTime=Thu Jan 23 07:54:07 CST 2025, time=2025-01-23, status=1, ipAttribution=新南威尔士), GetPortalCommentsPageByObjectIdResponse(id=2116289, encodeId=9ad2211628998, content=请问投了以后2月15 显示 with eidtor ，然后更新了日期2月21日，但是还是显示 with eidtor。这是代表还没送审吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1498, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=925a4886082, createdName=759706283, createdTime=Fri Feb 24 15:40:31 CST 2023, time=2023-02-24, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2221616, encodeId=a3e1222161693, content=revision submitted to journal 16天了，好慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1499, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ae035128370, createdName=1464e744m37暂无昵称, createdTime=Tue Aug 20 23:42:56 CST 2024, time=2024-08-20, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2113953, encodeId=a2762113953ec, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：心血管领域非常专业的杂志，认可度高。从投稿到接收用了5个月。重视动物实验和详细的机制，创新性强时数据量不大也可发表。杂志会邀请客座编辑对文章进行评估，一般都是领域内的大牛。外审意见返回后，客座编辑会综合意见并提出自己的看法和要求。杂志有专门的团队帮忙润色，水平非常高！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1652, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0da81966598, createdName=wslyxblxx, createdTime=Fri Feb 10 12:58:06 CST 2023, time=2023-02-10, status=1, ipAttribution=河南省)]

2025-06-16 ms7323538649197238 来自河南省

审稿速度:1.0 | 投稿命中率:25.0
经验分享：修回under review之后变成all review completed已经6天，还没有收到意见。

165 0 举报

[GetPortalCommentsPageByObjectIdResponse(id=2360820, encodeId=4df2236082078, content=投稿周期短，可以考虑～, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8f110016014, createdName=ms7000001543812798, createdTime=Thu Aug 27 11:00:41 CST 2026, time=2026-08-27, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2259893, encodeId=e9cf2259893e8, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：心脏瓣膜材料综述 经验分享：综述投稿 3月19 submitted to journal 3月27 直接就是Decision in Progress，这是什么意思，而且现在已经半个月还是Decision in Progress。有没有大佬经历过，求解答, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8599517450, createdName=ms5000001778422266, createdTime=Thu Apr 10 11:38:26 CST 2025, time=2025-04-10, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2166745, encodeId=e9ed2166e4569, content=10月24投的目前仍然submitted to journal 好慢啊有经验的大神可以告知下吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1178, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e6a65458119, createdName=ms1000001139242253, createdTime=Sun Nov 05 01:42:59 CST 2023, time=2023-11-05, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2130917, encodeId=c84f213091eac, content=投稿命中率:50.0 偏重的研究方向：心血管 经验分享：先看看吧，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1211, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2c38538526, createdName=ms7000002097157659, createdTime=Mon May 08 09:19:39 CST 2023, time=2023-05-08, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2269574, encodeId=d36a22695e428, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：修回under review之后变成all review completed已经6天，还没有收到意见。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJVbM5G1znabWwzvc0npgCQJMIpTJ2uiaNy7RDbTrjYicEw5DvukA50wqL8YJ8SzXEsxM7SPuzVeBibg/0, createdBy=20682164487, createdName=ms7323538649197238, createdTime=Mon Jun 16 10:16:25 CST 2025, time=2025-06-16, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2259889, encodeId=b6b722598892c, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：心脏瓣膜材料综述 经验分享：投稿综述 3月19 submitted to journal 3月27 直接就是Decision in Progress是什么意思，而且现在已经半个月了，还是Decision in Progress。 有经历过的大佬吗，求解答，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8599517450, createdName=ms5000001778422266, createdTime=Thu Apr 10 11:25:20 CST 2025, time=2025-04-10, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2249259, encodeId=32242249259d2, content=1.10 投稿 1.15 改格式 1.17 with editor 1.22 under review 这里的under review是外审吗？还是只是编辑内审呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=189, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230127/dd490db5809c41dba47efd8445d736af/b6403d79e2fb4308b2f2b14ee7a06741.jpg, createdBy=1f234693702, createdName=白衣13, createdTime=Thu Jan 23 07:54:07 CST 2025, time=2025-01-23, status=1, ipAttribution=新南威尔士), GetPortalCommentsPageByObjectIdResponse(id=2116289, encodeId=9ad2211628998, content=请问投了以后2月15 显示 with eidtor ，然后更新了日期2月21日，但是还是显示 with eidtor。这是代表还没送审吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1498, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=925a4886082, createdName=759706283, createdTime=Fri Feb 24 15:40:31 CST 2023, time=2023-02-24, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2221616, encodeId=a3e1222161693, content=revision submitted to journal 16天了，好慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1499, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ae035128370, createdName=1464e744m37暂无昵称, createdTime=Tue Aug 20 23:42:56 CST 2024, time=2024-08-20, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2113953, encodeId=a2762113953ec, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：心血管领域非常专业的杂志，认可度高。从投稿到接收用了5个月。重视动物实验和详细的机制，创新性强时数据量不大也可发表。杂志会邀请客座编辑对文章进行评估，一般都是领域内的大牛。外审意见返回后，客座编辑会综合意见并提出自己的看法和要求。杂志有专门的团队帮忙润色，水平非常高！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1652, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0da81966598, createdName=wslyxblxx, createdTime=Fri Feb 10 12:58:06 CST 2023, time=2023-02-10, status=1, ipAttribution=河南省)]

2025-04-10 ms5000001778422266 来自湖北省

审稿速度:6.0 | 投稿命中率:50.0
偏重的研究方向：心脏瓣膜材料综述
经验分享：投稿综述
3月19 submitted to journal
3月27 直接就是Decision in Progress是什么意思，而且现在已经半个月了，还是Decision in Progress。
有经历过的大佬吗，求解答，

210 0 举报

[GetPortalCommentsPageByObjectIdResponse(id=2360820, encodeId=4df2236082078, content=投稿周期短，可以考虑～, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8f110016014, createdName=ms7000001543812798, createdTime=Thu Aug 27 11:00:41 CST 2026, time=2026-08-27, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2259893, encodeId=e9cf2259893e8, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：心脏瓣膜材料综述 经验分享：综述投稿 3月19 submitted to journal 3月27 直接就是Decision in Progress，这是什么意思，而且现在已经半个月还是Decision in Progress。有没有大佬经历过，求解答, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8599517450, createdName=ms5000001778422266, createdTime=Thu Apr 10 11:38:26 CST 2025, time=2025-04-10, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2166745, encodeId=e9ed2166e4569, content=10月24投的目前仍然submitted to journal 好慢啊有经验的大神可以告知下吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1178, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e6a65458119, createdName=ms1000001139242253, createdTime=Sun Nov 05 01:42:59 CST 2023, time=2023-11-05, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2130917, encodeId=c84f213091eac, content=投稿命中率:50.0 偏重的研究方向：心血管 经验分享：先看看吧，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1211, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2c38538526, createdName=ms7000002097157659, createdTime=Mon May 08 09:19:39 CST 2023, time=2023-05-08, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2269574, encodeId=d36a22695e428, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：修回under review之后变成all review completed已经6天，还没有收到意见。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJVbM5G1znabWwzvc0npgCQJMIpTJ2uiaNy7RDbTrjYicEw5DvukA50wqL8YJ8SzXEsxM7SPuzVeBibg/0, createdBy=20682164487, createdName=ms7323538649197238, createdTime=Mon Jun 16 10:16:25 CST 2025, time=2025-06-16, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2259889, encodeId=b6b722598892c, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：心脏瓣膜材料综述 经验分享：投稿综述 3月19 submitted to journal 3月27 直接就是Decision in Progress是什么意思，而且现在已经半个月了，还是Decision in Progress。 有经历过的大佬吗，求解答，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8599517450, createdName=ms5000001778422266, createdTime=Thu Apr 10 11:25:20 CST 2025, time=2025-04-10, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2249259, encodeId=32242249259d2, content=1.10 投稿 1.15 改格式 1.17 with editor 1.22 under review 这里的under review是外审吗？还是只是编辑内审呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=189, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230127/dd490db5809c41dba47efd8445d736af/b6403d79e2fb4308b2f2b14ee7a06741.jpg, createdBy=1f234693702, createdName=白衣13, createdTime=Thu Jan 23 07:54:07 CST 2025, time=2025-01-23, status=1, ipAttribution=新南威尔士), GetPortalCommentsPageByObjectIdResponse(id=2116289, encodeId=9ad2211628998, content=请问投了以后2月15 显示 with eidtor ，然后更新了日期2月21日，但是还是显示 with eidtor。这是代表还没送审吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1498, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=925a4886082, createdName=759706283, createdTime=Fri Feb 24 15:40:31 CST 2023, time=2023-02-24, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2221616, encodeId=a3e1222161693, content=revision submitted to journal 16天了，好慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1499, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ae035128370, createdName=1464e744m37暂无昵称, createdTime=Tue Aug 20 23:42:56 CST 2024, time=2024-08-20, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2113953, encodeId=a2762113953ec, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：心血管领域非常专业的杂志，认可度高。从投稿到接收用了5个月。重视动物实验和详细的机制，创新性强时数据量不大也可发表。杂志会邀请客座编辑对文章进行评估，一般都是领域内的大牛。外审意见返回后，客座编辑会综合意见并提出自己的看法和要求。杂志有专门的团队帮忙润色，水平非常高！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1652, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0da81966598, createdName=wslyxblxx, createdTime=Fri Feb 10 12:58:06 CST 2023, time=2023-02-10, status=1, ipAttribution=河南省)]

2025-01-23 白衣13 来自新南威尔士

1.10 投稿
1.15 改格式
1.17 with editor
1.22 under review
这里的under review是外审吗？还是只是编辑内审呢？

189 4 举报

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2360820, encodeId=4df2236082078, content=投稿周期短，可以考虑～, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8f110016014, createdName=ms7000001543812798, createdTime=Thu Aug 27 11:00:41 CST 2026, time=2026-08-27, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2259893, encodeId=e9cf2259893e8, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：心脏瓣膜材料综述 经验分享：综述投稿 3月19 submitted to journal 3月27 直接就是Decision in Progress，这是什么意思，而且现在已经半个月还是Decision in Progress。有没有大佬经历过，求解答, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8599517450, createdName=ms5000001778422266, createdTime=Thu Apr 10 11:38:26 CST 2025, time=2025-04-10, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2166745, encodeId=e9ed2166e4569, content=10月24投的目前仍然submitted to journal 好慢啊有经验的大神可以告知下吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1178, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e6a65458119, createdName=ms1000001139242253, createdTime=Sun Nov 05 01:42:59 CST 2023, time=2023-11-05, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2130917, encodeId=c84f213091eac, content=投稿命中率:50.0 偏重的研究方向：心血管 经验分享：先看看吧，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1211, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2c38538526, createdName=ms7000002097157659, createdTime=Mon May 08 09:19:39 CST 2023, time=2023-05-08, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2269574, encodeId=d36a22695e428, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：修回under review之后变成all review completed已经6天，还没有收到意见。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJVbM5G1znabWwzvc0npgCQJMIpTJ2uiaNy7RDbTrjYicEw5DvukA50wqL8YJ8SzXEsxM7SPuzVeBibg/0, createdBy=20682164487, createdName=ms7323538649197238, createdTime=Mon Jun 16 10:16:25 CST 2025, time=2025-06-16, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2259889, encodeId=b6b722598892c, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：心脏瓣膜材料综述 经验分享：投稿综述 3月19 submitted to journal 3月27 直接就是Decision in Progress是什么意思，而且现在已经半个月了，还是Decision in Progress。 有经历过的大佬吗，求解答，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8599517450, createdName=ms5000001778422266, createdTime=Thu Apr 10 11:25:20 CST 2025, time=2025-04-10, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2249259, encodeId=32242249259d2, content=1.10 投稿 1.15 改格式 1.17 with editor 1.22 under review 这里的under review是外审吗？还是只是编辑内审呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=189, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230127/dd490db5809c41dba47efd8445d736af/b6403d79e2fb4308b2f2b14ee7a06741.jpg, createdBy=1f234693702, createdName=白衣13, createdTime=Thu Jan 23 07:54:07 CST 2025, time=2025-01-23, status=1, ipAttribution=新南威尔士), GetPortalCommentsPageByObjectIdResponse(id=2116289, encodeId=9ad2211628998, content=请问投了以后2月15 显示 with eidtor ，然后更新了日期2月21日，但是还是显示 with eidtor。这是代表还没送审吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1498, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=925a4886082, createdName=759706283, createdTime=Fri Feb 24 15:40:31 CST 2023, time=2023-02-24, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2221616, encodeId=a3e1222161693, content=revision submitted to journal 16天了，好慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1499, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ae035128370, createdName=1464e744m37暂无昵称, createdTime=Tue Aug 20 23:42:56 CST 2024, time=2024-08-20, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2113953, encodeId=a2762113953ec, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：心血管领域非常专业的杂志，认可度高。从投稿到接收用了5个月。重视动物实验和详细的机制，创新性强时数据量不大也可发表。杂志会邀请客座编辑对文章进行评估，一般都是领域内的大牛。外审意见返回后，客座编辑会综合意见并提出自己的看法和要求。杂志有专门的团队帮忙润色，水平非常高！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1652, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0da81966598, createdName=wslyxblxx, createdTime=Fri Feb 10 12:58:06 CST 2023, time=2023-02-10, status=1, ipAttribution=河南省)]

2023-02-24 759706283 来自陕西省

请问投了以后2月15 显示 with eidtor ，然后更新了日期2月21日，但是还是显示 with eidtor。这是代表还没送审吗

1498 1 举报

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2360820, encodeId=4df2236082078, content=投稿周期短，可以考虑～, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8f110016014, createdName=ms7000001543812798, createdTime=Thu Aug 27 11:00:41 CST 2026, time=2026-08-27, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2259893, encodeId=e9cf2259893e8, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：心脏瓣膜材料综述 经验分享：综述投稿 3月19 submitted to journal 3月27 直接就是Decision in Progress，这是什么意思，而且现在已经半个月还是Decision in Progress。有没有大佬经历过，求解答, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8599517450, createdName=ms5000001778422266, createdTime=Thu Apr 10 11:38:26 CST 2025, time=2025-04-10, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2166745, encodeId=e9ed2166e4569, content=10月24投的目前仍然submitted to journal 好慢啊有经验的大神可以告知下吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1178, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e6a65458119, createdName=ms1000001139242253, createdTime=Sun Nov 05 01:42:59 CST 2023, time=2023-11-05, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2130917, encodeId=c84f213091eac, content=投稿命中率:50.0 偏重的研究方向：心血管 经验分享：先看看吧，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1211, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2c38538526, createdName=ms7000002097157659, createdTime=Mon May 08 09:19:39 CST 2023, time=2023-05-08, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2269574, encodeId=d36a22695e428, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：修回under review之后变成all review completed已经6天，还没有收到意见。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJVbM5G1znabWwzvc0npgCQJMIpTJ2uiaNy7RDbTrjYicEw5DvukA50wqL8YJ8SzXEsxM7SPuzVeBibg/0, createdBy=20682164487, createdName=ms7323538649197238, createdTime=Mon Jun 16 10:16:25 CST 2025, time=2025-06-16, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2259889, encodeId=b6b722598892c, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：心脏瓣膜材料综述 经验分享：投稿综述 3月19 submitted to journal 3月27 直接就是Decision in Progress是什么意思，而且现在已经半个月了，还是Decision in Progress。 有经历过的大佬吗，求解答，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8599517450, createdName=ms5000001778422266, createdTime=Thu Apr 10 11:25:20 CST 2025, time=2025-04-10, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2249259, encodeId=32242249259d2, content=1.10 投稿 1.15 改格式 1.17 with editor 1.22 under review 这里的under review是外审吗？还是只是编辑内审呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=189, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230127/dd490db5809c41dba47efd8445d736af/b6403d79e2fb4308b2f2b14ee7a06741.jpg, createdBy=1f234693702, createdName=白衣13, createdTime=Thu Jan 23 07:54:07 CST 2025, time=2025-01-23, status=1, ipAttribution=新南威尔士), GetPortalCommentsPageByObjectIdResponse(id=2116289, encodeId=9ad2211628998, content=请问投了以后2月15 显示 with eidtor ，然后更新了日期2月21日，但是还是显示 with eidtor。这是代表还没送审吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1498, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=925a4886082, createdName=759706283, createdTime=Fri Feb 24 15:40:31 CST 2023, time=2023-02-24, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2221616, encodeId=a3e1222161693, content=revision submitted to journal 16天了，好慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1499, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ae035128370, createdName=1464e744m37暂无昵称, createdTime=Tue Aug 20 23:42:56 CST 2024, time=2024-08-20, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2113953, encodeId=a2762113953ec, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：心血管领域非常专业的杂志，认可度高。从投稿到接收用了5个月。重视动物实验和详细的机制，创新性强时数据量不大也可发表。杂志会邀请客座编辑对文章进行评估，一般都是领域内的大牛。外审意见返回后，客座编辑会综合意见并提出自己的看法和要求。杂志有专门的团队帮忙润色，水平非常高！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1652, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0da81966598, createdName=wslyxblxx, createdTime=Fri Feb 10 12:58:06 CST 2023, time=2023-02-10, status=1, ipAttribution=河南省)]

2024-08-20 1464e744m37暂无昵称来自四川省

revision submitted to journal 16天了，好慢

1499 9 举报

展开9条回复

[GetPortalCommentsPageByObjectIdResponse(id=2360820, encodeId=4df2236082078, content=投稿周期短，可以考虑～, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8f110016014, createdName=ms7000001543812798, createdTime=Thu Aug 27 11:00:41 CST 2026, time=2026-08-27, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2259893, encodeId=e9cf2259893e8, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：心脏瓣膜材料综述 经验分享：综述投稿 3月19 submitted to journal 3月27 直接就是Decision in Progress，这是什么意思，而且现在已经半个月还是Decision in Progress。有没有大佬经历过，求解答, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8599517450, createdName=ms5000001778422266, createdTime=Thu Apr 10 11:38:26 CST 2025, time=2025-04-10, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2166745, encodeId=e9ed2166e4569, content=10月24投的目前仍然submitted to journal 好慢啊有经验的大神可以告知下吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1178, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e6a65458119, createdName=ms1000001139242253, createdTime=Sun Nov 05 01:42:59 CST 2023, time=2023-11-05, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2130917, encodeId=c84f213091eac, content=投稿命中率:50.0 偏重的研究方向：心血管 经验分享：先看看吧，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1211, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2c38538526, createdName=ms7000002097157659, createdTime=Mon May 08 09:19:39 CST 2023, time=2023-05-08, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2269574, encodeId=d36a22695e428, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：修回under review之后变成all review completed已经6天，还没有收到意见。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJVbM5G1znabWwzvc0npgCQJMIpTJ2uiaNy7RDbTrjYicEw5DvukA50wqL8YJ8SzXEsxM7SPuzVeBibg/0, createdBy=20682164487, createdName=ms7323538649197238, createdTime=Mon Jun 16 10:16:25 CST 2025, time=2025-06-16, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2259889, encodeId=b6b722598892c, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：心脏瓣膜材料综述 经验分享：投稿综述 3月19 submitted to journal 3月27 直接就是Decision in Progress是什么意思，而且现在已经半个月了，还是Decision in Progress。 有经历过的大佬吗，求解答，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8599517450, createdName=ms5000001778422266, createdTime=Thu Apr 10 11:25:20 CST 2025, time=2025-04-10, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2249259, encodeId=32242249259d2, content=1.10 投稿 1.15 改格式 1.17 with editor 1.22 under review 这里的under review是外审吗？还是只是编辑内审呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=189, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230127/dd490db5809c41dba47efd8445d736af/b6403d79e2fb4308b2f2b14ee7a06741.jpg, createdBy=1f234693702, createdName=白衣13, createdTime=Thu Jan 23 07:54:07 CST 2025, time=2025-01-23, status=1, ipAttribution=新南威尔士), GetPortalCommentsPageByObjectIdResponse(id=2116289, encodeId=9ad2211628998, content=请问投了以后2月15 显示 with eidtor ，然后更新了日期2月21日，但是还是显示 with eidtor。这是代表还没送审吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1498, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=925a4886082, createdName=759706283, createdTime=Fri Feb 24 15:40:31 CST 2023, time=2023-02-24, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2221616, encodeId=a3e1222161693, content=revision submitted to journal 16天了，好慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1499, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ae035128370, createdName=1464e744m37暂无昵称, createdTime=Tue Aug 20 23:42:56 CST 2024, time=2024-08-20, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2113953, encodeId=a2762113953ec, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：心血管领域非常专业的杂志，认可度高。从投稿到接收用了5个月。重视动物实验和详细的机制，创新性强时数据量不大也可发表。杂志会邀请客座编辑对文章进行评估，一般都是领域内的大牛。外审意见返回后，客座编辑会综合意见并提出自己的看法和要求。杂志有专门的团队帮忙润色，水平非常高！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1652, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0da81966598, createdName=wslyxblxx, createdTime=Fri Feb 10 12:58:06 CST 2023, time=2023-02-10, status=1, ipAttribution=河南省)]

2023-02-10 wslyxblxx 来自河南省

审稿速度:3.0 | 投稿命中率:25.0
经验分享：心血管领域非常专业的杂志，认可度高。从投稿到接收用了5个月。重视动物实验和详细的机制，创新性强时数据量不大也可发表。杂志会邀请客座编辑对文章进行评估，一般都是领域内的大牛。外审意见返回后，客座编辑会综合意见并提出自己的看法和要求。杂志有专门的团队帮忙润色，水平非常高！

1652 5 举报

展开5条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务